These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3137696)

  • 21. Short-term effect on growth of two doses of GRF 1-44 in children with growth hormone deficiency: comparison with growth induced by methionyl-GH administration.
    Wit JM; Otten BJ; Waelkens JJ; Oostdijk W; Krabbe J; Rochefort JG; Van den Brande JL
    Horm Res; 1987; 27(4):181-9. PubMed ID: 3125098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of children with slow growth: how much of what for whom?].
    Wit JM
    Ned Tijdschr Geneeskd; 1990 May; 134(18):899-904. PubMed ID: 2111882
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of a long-term methionyl growth hormone treatment on growth hormone releasing hormone-induced growth hormone secretion in patients with constitutional growth delay.
    Sartorio A; Conti A; Morabito F; Faglia G
    Eur J Pediatr; 1992 Feb; 151(2):148-9. PubMed ID: 1537361
    [No Abstract]   [Full Text] [Related]  

  • 24. Growth hormone: diagnostic and therapeutic dilemmas.
    Morris AH; Reiter EO
    Semin Adolesc Med; 1987 Dec; 3(4):283-91. PubMed ID: 3324248
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.
    Mohn A; Marzio D; Giannini C; Capanna R; Marcovecchio M; Chiarelli F
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):537-42. PubMed ID: 16268806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use--and misuse--of growth hormone.
    Allen DB; Blizzard RM; Rosenfeld RG
    Contemp Pediatr; 1995 Sep; 12(9):45-6, 49-50, 53-4 passim. PubMed ID: 10155577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution therapy with recombinant growth hormone (somatrem) in adults with growth hormone deficiency.
    Degerblad M; Grunditz R; Hall K; Sjöberg HE; Sääf M; Thorén M
    Acta Paediatr Scand Suppl; 1987; 337():170-1. PubMed ID: 3481181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy with growth hormone in pediatric patients with chronic kidney insufficiency].
    Hämmerli I; Neuhaus T; Leumann E; Nüssli R; Vischer D; Zachmann M
    Schweiz Med Wochenschr; 1994 Sep; 124(36):1575-80. PubMed ID: 7939524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of recombinant growth hormone in children with kidney failure].
    Broyer M; Rappaport R
    Arch Pediatr; 1994 Aug; 1(8):706-8. PubMed ID: 7842102
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-conventional growth hormone treatment in short children.
    Westphal O
    Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():10-1. PubMed ID: 8342384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Somatocrinin induces growth hormone release in a case of growth hormone deficiency of hypothalamic origin in a child].
    Sassolas G; Rousset H; Cohen R; Chatelain P; Claustrat B; Laporte S; Laferrère B; El Charfi A; Ferry S
    C R Seances Acad Sci III; 1983; 296(11):527-30. PubMed ID: 6409361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of short-term lower leg growth with statural growth in children treated with growth promoting substances.
    Wit JM; Teunissen DM; Waelkens JJ; Gerver WJ
    Acta Paediatr Scand Suppl; 1987; 337():40-3. PubMed ID: 3124497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human growth hormone therapy: longterm responses in 30 children with growth hormone deficiency.
    Kannan V; Usharani K
    Indian J Pediatr; 1991; 58 Suppl 1():65-9. PubMed ID: 1824378
    [No Abstract]   [Full Text] [Related]  

  • 34. Titration of growth hormone dose using insulin-like growth factor-1 measurements: is it feasible in children?
    Bercu BB
    J Pediatr; 2002 Nov; 141(5):601-5. PubMed ID: 12410184
    [No Abstract]   [Full Text] [Related]  

  • 35. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP; Van Meter QL; Kowarski AA
    Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant human growth hormone on graft function in renal-transplanted children and adolescents: the three-year experience of a Belgian study group.
    Janssen F; Van Damme-Lombaerts R; Van Dyck M; Hall M; Proesmans W; Goos G; Kinnaert P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1049-50. PubMed ID: 8442037
    [No Abstract]   [Full Text] [Related]  

  • 37. [Historical perspective on growth hormone treatment in children].
    Wit JM
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):135-9. PubMed ID: 1448803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternatives to growth hormone.
    Lancet; 1989 Apr; 1(8642):820-2. PubMed ID: 2564906
    [No Abstract]   [Full Text] [Related]  

  • 39. Which children should have growth hormone therapy?
    Milner RD
    Lancet; 1986 Mar; 1(8479):483-5. PubMed ID: 2869217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.